BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29485078)

  • 21. Incidence and relapse risk of intracranial metastases within the perihippocampal region in 314 patients with breast cancer.
    Sun B; Huang Z; Wu S; Shen G; Cha L; Meng X; Ding L; Wang J; Song S
    Radiother Oncol; 2016 Jan; 118(1):181-6. PubMed ID: 26674923
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hippocampal sparing radiotherapy for pediatric medulloblastoma: impact of treatment margins and treatment technique.
    Brodin NP; Munck af Rosenschöld P; Blomstrand M; Kiil-Berthlesen A; Hollensen C; Vogelius IR; Lannering B; Bentzen SM; Björk-Eriksson T
    Neuro Oncol; 2014 Apr; 16(4):594-602. PubMed ID: 24327585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. White matter lesions detected by magnetic resonance imaging after radiotherapy and high-dose chemotherapy in children with medulloblastoma or primitive neuroectodermal tumor.
    Fouladi M; Chintagumpala M; Laningham FH; Ashley D; Kellie SJ; Langston JW; McCluggage CW; Woo S; Kocak M; Krull K; Kun LE; Mulhern RK; Gajjar A
    J Clin Oncol; 2004 Nov; 22(22):4551-60. PubMed ID: 15542806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Late toxicity following craniospinal radiation for early-stage medulloblastoma.
    Christopherson KM; Rotondo RL; Bradley JA; Pincus DW; Wynn TT; Fort JA; Morris CG; Mendenhall NP; Marcus RB; Indelicato DJ
    Acta Oncol; 2014 Apr; 53(4):471-80. PubMed ID: 24564687
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impaired Recent, but Preserved Remote, Autobiographical Memory in Pediatric Brain Tumor Patients.
    Sekeres MJ; Riggs L; Decker A; de Medeiros CB; Bacopulos A; Skocic J; Szulc-Lerch K; Bouffet E; Levine B; Grady CL; Mabbott DJ; Josselyn SA; Frankland PW
    J Neurosci; 2018 Sep; 38(38):8251-8261. PubMed ID: 30126966
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Multi-institution prospective trial of reduced-dose craniospinal irradiation (23.4 Gy) followed by conformal posterior fossa (36 Gy) and primary site irradiation (55.8 Gy) and dose-intensive chemotherapy for average-risk medulloblastoma.
    Merchant TE; Kun LE; Krasin MJ; Wallace D; Chintagumpala MM; Woo SY; Ashley DM; Sexton M; Kellie SJ; Ahern V; Gajjar A
    Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):782-7. PubMed ID: 17892918
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pediatric medulloblastoma: radiation treatment technique and patterns of failure.
    Miralbell R; Bleher A; Huguenin P; Ries G; Kann R; Mirimanoff RO; Notter M; Nouet P; Bieri S; Thum P; Toussi H
    Int J Radiat Oncol Biol Phys; 1997 Feb; 37(3):523-9. PubMed ID: 9112448
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques?
    Lee CT; Bilton SD; Famiglietti RM; Riley BA; Mahajan A; Chang EL; Maor MH; Woo SY; Cox JD; Smith AR
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):362-72. PubMed ID: 16168831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preclinical Modeling of Image-Guided Craniospinal Irradiation for Very-High-Risk Medulloblastoma.
    Smith SMC; Bianski BM; Orr BA; Harknett G; Onar-Thomas A; Gilbertson RJ; Merchant TE; Roussel MF; Tinkle CL
    Int J Radiat Oncol Biol Phys; 2019 Mar; 103(3):728-737. PubMed ID: 30366006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of supine and prone craniospinal irradiation in children with medulloblastoma.
    Verma J; Mazloom A; Teh BS; South M; Butler EB; Paulino AC
    Pract Radiat Oncol; 2015; 5(2):93-8. PubMed ID: 25413414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of high-risk medulloblastoma and other primitive neuroectodermal tumors with reduced dose craniospinal radiation therapy and multi-agent nitrosourea-based chemotherapy.
    Prados MD; Wara W; Edwards MS; Ater J; Rabbit J; Lamborn K; Davis R; Levin VA
    Pediatr Neurosurg; 1996 Oct; 25(4):174-81. PubMed ID: 9293544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of the incidence and patterns of second neoplasms after photon craniospinal irradiation in children with medulloblastoma.
    Bavle A; Tewari S; Sisson A; Chintagumpala M; Anderson M; Paulino AC
    Pediatr Blood Cancer; 2018 Aug; 65(8):e27095. PubMed ID: 29693784
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Perihippocampal failure after hippocampal-avoidance whole-brain radiotherapy in cancer patients with brain metastases: Results of a retrospective analysis.
    Shieh LT; Lee SW; Chen CC; Ho YC; Wang YW; Ho SY
    Medicine (Baltimore); 2022 Apr; 101(14):e29144. PubMed ID: 35446298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma : First experiences of the German radiotherapy quality control panel in the SIOP PNET5 MB trial.
    Dietzsch S; Braesigk A; Seidel C; Remmele J; Kitzing R; Schlender T; Mynarek M; Geismar D; Jablonska K; Schwarz R; Pazos M; Walser M; Frick S; Gurtner K; Matuschek C; Harrabi SB; Glück A; Lewitzki V; Dieckmann K; Benesch M; Gerber NU; Rutkowski S; Timmermann B; Kortmann RD
    Strahlenther Onkol; 2021 Aug; 197(8):674-682. PubMed ID: 33226469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hippocampal sparing approach in fractionated stereotactic brain VMAT radio therapy: A retrospective feasibility analysis.
    Daniela Falco M; Giancaterino S; D'Andrea M; Gimenez De Lorenzo R; Trignani M; Caravatta L; Di Carlo C; Di Biase S; Allajbej A; Genovesi D
    J Appl Clin Med Phys; 2018 Jan; 19(1):86-93. PubMed ID: 29125239
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: A Children's Cancer Group Study.
    Packer RJ; Goldwein J; Nicholson HS; Vezina LG; Allen JC; Ris MD; Muraszko K; Rorke LB; Wara WM; Cohen BH; Boyett JM
    J Clin Oncol; 1999 Jul; 17(7):2127-36. PubMed ID: 10561268
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment Design and Rationale for a Randomized Trial of Prophylactic Cranial Irradiation With or Without Hippocampal Avoidance for SCLC: PREMER Trial on Behalf of the Oncologic Group for the Study of Lung Cancer/Spanish Radiation Oncology Group-Radiation Oncology Clinical Research Group.
    Rodríguez de Dios N; Couñago F; López JL; Calvo P; Murcia M; Rico M; Vallejo C; Luna J; Trueba I; Cigarral C; Farre N; Manero RM; Durán X; Samper P
    Clin Lung Cancer; 2018 Sep; 19(5):e693-e697. PubMed ID: 29891263
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longterm treatment results of childhood medulloblastoma by craniospinal irradiation in supine position.
    Slampa P; Pavelka Z; Dusek L; Hynkova L; Sterba J; Ondrova B; Princ D; Novotny T; Kostakova S
    Neoplasma; 2007; 54(1):62-7. PubMed ID: 17203894
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome and toxicity using helical tomotherapy for craniospinal irradiation in pediatric medulloblastoma.
    Lopez Guerra JL; Marrone I; Jaen J; Bruna M; Sole C; Sanchez-Reyes A; Rivin E; Ortiz MJ; Calvo F; Matute R
    Clin Transl Oncol; 2014 Jan; 16(1):96-101. PubMed ID: 23632814
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular characterization of long-term survivors of metastatic medulloblastoma treated with reduced-dose craniospinal irradiation.
    Irikura T; Fukuoka K; Nakazawa A; Ichimura K; Kurihara J; Koh K
    Childs Nerv Syst; 2023 Sep; 39(9):2505-2507. PubMed ID: 37185696
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.